New England Journal of Medicine
The New England Journal of Medicine publishes new medical research, review articles, and editorial opinion on a wide variety of topics.
The New England Journal of Medicine | Research & Review Articles …
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
Current Issue | New England Journal of Medicine
Case Records of the Massachusetts General Hospital. Case 2-2025: A 21-Year-Old Man with Loss of Consciousness and a Fall. E.F. Shappell and Others
Ivermectin Treatment for Covid-19 | New England Journal of …
Dec 14, 2022 · Reis et al. (May 5 issue) 1 present the results of the TOGETHER platform trial, a large trial of ivermectin in outpatients with Covid-19. The relative risk of hospitalization or prolonged ...
NEJM Author Center - The New England Journal of Medicine
Welcome. Thank you for considering the New England Journal of Medicine (NEJM) for your manuscript.. The NEJM Author Center provides an array of informational resources to help guide you through ...
Effect of Early Treatment with Ivermectin among Patients with …
Mar 30, 2022 · A total of 3515 patients were randomly assigned to receive ivermectin (679 patients), placebo (679), or another intervention (2157). Overall, 100 patients (14.7%) in the ivermectin group had a ...
Recently Published - The New England Journal of Medicine
Dec 31, 2024 · The BALANCE Investigators, for the Canadian Critical Care Trials Group, the Association of Medical Microbiology and Infectious Disease Canada Clinical Research Network, the Australian and New ...
Cardiology - The New England Journal of Medicine
In patients with atrial fibrillation and moderate-to-high risk of stroke, abelacimab, a monoclonal antibody that inhibits activation of factor XI, led to fewer bleeding events than rivaroxaban.
Coronavirus (Covid-19) | NEJM
Jul 17, 2024 · Explore a collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Dec 10, 2020 · A total of 43,548 participants underwent randomization, of whom 43,448 received injections: 21,720 with BNT162b2 and 21,728 with placebo. There were 8 cases of Covid-19 with onset at least 7 days ...